foxo4 dri senolytic peptide human trial 2024 Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics Senolytic Interventions for Type 2
Description
Cardiovascular disease (CVD) CVD is the leading cause of death in patients with CKD
Marek, 2017
At 12mg, 24.2%
00300-7/asset/fc51add5-22b1-4645-9507-e89d0738c67a/main.assets/gr1_lrg.jpg)
However, the drug is associated with mild to moderate gastrointestinal side effects, as well as potential brain-related side effects such as irritability, anxiety, and sleep troubles
